CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells
about
CD40L and Its Receptors in Atherothrombosis-An UpdateSomatic mutation as a mechanism of Wnt/β-catenin pathway activation in CLL.Considerations for combined immune checkpoint modulation and radiation treatment.Multifunctional CD40L: pro- and anti-neoplastic activity.Autologous CLL cell vaccination early after transplant induces leukemia-specific T cellsImmunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1).Efficient generation of antigen-specific CTLs by the BAFF-activated human B Lymphocytes as APCs: a novel approach for immunotherapy.CD40-activated B cells as antigen-presenting cells: the final sprint toward clinical application.Galectin-9 suppresses B cell receptor signaling and is regulated by I-branching of N-glycansEngineering of Primary Human B cells with CRISPR/Cas9 Targeted NucleaseCombination anti-PD-1 and antiretroviral therapy provides therapeutic benefit against SIV
P2860
Q33814059-A0B716A9-3EC3-4D51-842D-9B4749625922Q34047852-4697EBFE-6CC4-4B1B-9B4F-37FE51997BF6Q34174871-90CB7FB6-C6E0-484C-B1A4-89930744B793Q34422566-93A56768-44B2-40A3-88EF-8C517B25D2F4Q37123927-C9AC11C7-4BD8-45A7-83F1-102B5C78C6AFQ37173264-5AA7FFAA-D4F5-4C8A-9A0A-9930FA4B4818Q37718429-4BD9D926-1C14-41D2-8C57-DEE974982AFBQ38113268-3FB846FF-4C6C-4ADA-B4A0-C2A1C1AC52A3Q58771173-1EA9AD1C-86C9-46D8-8C5E-9FA712AEA0C7Q58782953-1CCFCD33-1137-45F2-B382-745D79BA7BEBQ59125545-5A1A7EB0-3B25-4586-A848-B35CC4CF3559
P2860
CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
CD40L-Tri, a novel formulation ...... effectively activates B cells
@ast
CD40L-Tri, a novel formulation ...... effectively activates B cells
@en
type
label
CD40L-Tri, a novel formulation ...... effectively activates B cells
@ast
CD40L-Tri, a novel formulation ...... effectively activates B cells
@en
prefLabel
CD40L-Tri, a novel formulation ...... effectively activates B cells
@ast
CD40L-Tri, a novel formulation ...... effectively activates B cells
@en
P2093
P2860
P1476
CD40L-Tri, a novel formulation ...... effectively activates B cells
@en
P2093
Anselmo Alonso
Baogong Zhu
Catherine J Wu
Deborah Ahove
Donna Neuberg
Elizabeth Witten
Gordon J Freeman
Jonathan S Duke-Cohan
Ken-Ichi Matsuoka
P2860
P2888
P304
P356
10.1007/S00262-012-1331-4
P577
2012-08-25T00:00:00Z